Stock Market & Financial News
USD/CHF Price Forecast: Retakes 0.8100; eyes YTD high set on Tuesday amid bullish setup
USD/CHF Price Forecast: Retakes 0.8100; eyes YTD high set on Tuesday amid bullish setup
Silver Risks Falling to $50 as Dollar Holds Firm and Solar Demand Shifts
Silver's recovery lost momentum below the $60 mark this week despite softer-than-expected US inflation, highlighting a macro backdrop that has become less supportive than many investors anticipated. Ordinarily, a downside surprise in CPI would trigger a broader Dollar selloff and provide precious metals with a meaningful tailwind.
3 stocks riding the wave from IBM's earnings disaster
IBM stock suffered its worst one-day decline on record after the technology group admitted that customers were moving money away from its products and towards urgently needed data-centre infrastructure. The stock plunged 25.2% to $217.07 on Tuesday, leaving it just above its 52-week low, after preliminary second-quarter revenue and profit missed Wall Street forecasts.
IBM Bitcoin Rebounds to $64,700 as Falling Volume, Exchange Inflows Signal Weak Conviction
Bitcoin (BTC) rebounded to $64,784 on Wednesday ET, easing some of the market's recent stress, but the recovery is being met with a notable decline in trading activity and renewed inflows to exchanges—signals that suggest the move may lack broad conviction. As of 12:01 a.m.
Melco Resorts & Entertainment: The Worst Is Behind Us
Melco Resorts & Entertainment remains a BUY as World Cup-driven Macau weakness appears priced in and fundamentals should strengthen into August's peak visitation. MLCO's 1Q26 Macau EBITDA grew 16% YoY with margins up to 27.4%, outperforming Las Vegas Sands in margin resilience. MLCO trades at 6.5x forward EV/EBITDA, a 17% discount to LVS and 36% below the consumer discretionary sector, with robust forward growth metrics.
MLCO 
PayPal jumps 15% in premarket trading on reports Stripe, Advent are weighing $53 billion takeover
Stripe and Advent International have reportedly made a joint offer to acquire PayPal Holdings Inc for $60.50 per share, in a deal that would value the payments company at more than $53 billion.
PYPL 
PayPal stock jumps on Stripe, Advent acquisition rumors: what went wrong?
PayPal's stock surged in premarket trading after reports emerged that Stripe and Advent International had offered to acquire the company for over $53 billion. The offer, valued at $60.50 per share, represents roughly a 28% premium over PayPal's most recent closing price.
PYPL 
A $53 billion lifeline? Stripe and Advent reportedly team up to bid for battered PayPal.
PayPal, the struggling payments processor, rallied in premarket trade on Wednesday on a report that rival Stripe is teaming up with private-equity group Advent International on a bid.
ADN 
Live markets: Bitcoin, ether ETFs draw inflows as majors rise as much as 5%
U.S. spot bitcoin ETFs took in about $181 million on Tuesday, a day after shedding roughly $425 million, per SoSoValue data. Ether ETFs added about $58 million.
Liberty Energy: Oh My, Have Things Changed (Rating Upgrade)
Liberty Energy is upgraded to BUY as it aggressively expands its power generation business, targeting 3 GW deployable capacity by 2029. LBRT's power division, supported by a strategic SLB partnership, is projected to deliver 20% CAGR and high-teen returns through long-term PPAs. The company's diversified earnings base—power plus recovering completions—supports a higher, sustainable 9x EV/EBITDA multiple and robust long-term growth.
LBRT 
Aura Minerals: Multiple Catalysts Could Drive Significant Upside
Aura Minerals receives a Buy rating, supported by a high-quality asset base, robust production growth, and strong execution. AUGO's diversified gold and copper portfolio, second-quartile AISC, and disciplined capital allocation underpin its competitive positioning and risk mitigation. Key catalysts include Era Dorada's development, Matupá FID, and copper portfolio expansion, with potential production growth from 500 koz to 800–1,000 koz.
MTX 
ISD: Downside Could Be Limited From Here If The Fund Can Sustain Its Distribution
PGIM High Yield Bond Fund offers a 9.87% yield by investing primarily in junk bonds and loans to lower-credit companies. ISD's share price has underperformed both its net asset value and the high-yield index, reflecting a swing from premium to discount valuation. Distribution coverage is marginal, with recent periods showing distributions slightly exceeding income and gains; sustainability is a concern.
ISD 
Intraday Analysis 15.07.2026
AUDUSD (The Australian dollar) remains choppy AUDUSD (The Australian dollar) remained choppy as consumer confidence jumped out of negative territory. • As the pair searches for a recovery to the previous swing high at 0.6980, a bearish RSI divergence could signal a halt to the potential rally.
AUD/USD and USD/CAD React to Softer US Inflation
Commodity-linked currencies strengthened after US inflation data came in weaker than expected. The Consumer Price Index (CPI) slowed to 3.5% year-on-year in June, below the 3.8% forecast, while core inflation eased to 2.6% versus expectations of 2.8%.
Navan: Customer Ramps And AI Leverage
Navan earns a buy rating due to its deeply embedded, all-in-one business travel and expense platform, driving strong customer retention. NAVN's long growth runway is supported by multi-year customer ramping, expanding product adoption, and increasing enterprise wins, evidenced by 45 S&P 500 customers in Q1 2027. AI-driven automation, especially the Ava assistant, is significantly reducing support costs and expanding gross margins, reaching 75% in Q1 2027.
NAVN 
$1.2B Bloodbath as DOGE, SHIB, PEPE Face Massive Selling Pressure
In another indicator of shifting sentiment on major exchanges, a $1.2 billion difference between buy and sell orders was observed for memecoins on Binance.
AI Crypto SYN Sinks 55% After Arthur Hayes' Bullish Endorsement
SYN has crashed over 65% from its June peak, leaving Arthur Hayes down around $610,000 as technicals warn of a drop toward $0.175.
Workday: The Market Underestimates Profit Growth
Workday receives a Strong Buy rating at $145, with valuation at 13.5x FY2027 and 11.5x FY2028 earnings, reflecting market pessimism. Agentic AI is driving larger expansion deals, with new contract value up over 200% year-over-year, though its revenue contribution remains undisclosed. WDAY's platform expansion, high gross retention (97%), and margin improvements support profit growth, aided by significant share buybacks.
WDAY 
GBP/USD Awaits Political News: What Will Happen Next
GBP/USD rose to 1.3403 on Wednesday, with British politics taking centre stage for investors. The market is assessing the upcoming change of prime minister, with Andy Burnham set to take office on 20 July.
Syndax Pharmaceuticals, Inc. (SNDX) Discusses Pipeline Expansion and Next Phase of Innovation for Lead Therapies Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Discusses Pipeline Expansion and Next Phase of Innovation for Lead Therapies Transcript
SNDX 
Crypto Analysts Sound Alarm On Crumbling XRP Demand Under Pressure
Crypto's sell pressure is outweighing buying interest for another month as most altcoins lose institutional capital.
Bitcoin (BTC) Surges Past $64K as Cooling Inflation Data Crushes Fed Rate Hike Expectations
June's inflation figures came in below market expectations, triggering swift market action. Digital assets rallied, equity indices pushed higher, and expectations for additional Federal Reserve tightening evaporated almost immediately.
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
Celcuity NASDAQ: CELC said the U.S. Food and Drug Administration has granted full approval to gedatolisib, now branded as REVTORPYK, for certain patients with advanced breast cancer, marking the company's transition to a commercial-stage business.
CELC 
FIS Sees $42 Billion Opportunity in Offers Consumers Never Receive
Watch more: Need to Know | FIS | Mladen Vladic The next contest for cardholder loyalty may depend less on rewards programs than on whether consumers receive relevant offers before they decide how to pay.
FIS 
Morgan Stanley Updates Ethereum and Solana ETF Documents, Coinbase Tapped for Custody and Staking
Morgan Stanley has updated documents tied to its proposed Ethereum and Solana ETFs, with the revised paperwork naming Coinbase for custody and staking services. The change is a filing update to product documentation, not a regulatory approval, and it clarifies which service provider would handle asset safekeeping and staking if the products move forward.
Bitmine (BTMN) Stock Rockets 22x on Ethereum Staking — Despite $9.1B Non-Cash Loss
Bitmine Immersion Technologies delivered one of the crypto sector's most striking quarterly performances this earnings cycle. The company reported $46.5 million in revenue for the quarter ending May 31—a dramatic surge from approximately $2 million in the same period last year.
Avalanche (AVAX) Eyes Recovery as RWA Assets Surge Past $2.1 Billion
Avalanche's native token is hovering near the $6.49 level following a relatively subdued trading period over the past day. Despite the consolidation, technical patterns are beginning to emerge that suggest a possible reversal, though recent whale movements have introduced an element of uncertainty.
London BTC Company expands Nevada portfolio
London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) told investors it has expanded its Nevada precious-metals portfolio after surface sampling at its newly staked Black Star project returned grades of up to 16.23 grams per tonne gold and 50.5 g/t silver. The company secured 36 mineral claims covering 744 acres in Pershing County, around 16 miles from the Hycroft mine.
BTC 
Hemab Therapeutics: A Cash-Rich Coagulation Franchise With Multiple Clinical Catalysts
Hemab Therapeutics is building a differentiated coagulation franchise targeting underserved rare bleeding disorders with a prophylactic approach. COAG's robust cash position post-IPO funds operations into 2029, supporting multiple clinical catalysts across sutacimig, HMB-002, and preclinical HMB-003. Lead asset sutacimig shows strong Phase 2 efficacy and FDA-aligned Phase 3 dosing, while HMB-002 and HMB-003 broaden addressable markets.
FRG 
TSMC stock braces for record earnings, but this Nvidia risk could derail the rally
TSMC is expected to deliver another record profit on Thursday, but investors may need more than strong headline numbers to push the stock higher. The chipmaker reports at 2 AM ET on July 16.
NVDA 
